Literature DB >> 11739418

Phenotypes Associated with SHOX Deficiency.

J L Ross1, C Scott, P Marttila, K Kowal, A Nass, P Papenhausen, J Abboudi, L Osterman, H Kushner, P Carter, M Ezaki, F Elder, F Wei, H Chen, A R Zinn.   

Abstract

Leri-Weill dyschondrosteosis (LWD) (MIM 127300) is a dominantly inherited skeletal dysplasia characterized phenotypically by Madelung wrist deformity, mesomelia, and short stature. LWD can now be defined genetically by haploinsufficiency of the SHOX (short stature homeobox-containing) gene. We have studied 21 LWD families (43 affected LWD subjects, including 32 females and 11 males, ages 3-56 yr) with confirmed SHOX abnormalities. We investigated the relationship between SHOX mutations, height deficit, and Madelung deformity to determine the contribution of SHOX haploinsufficiency to the LWD and Turner syndrome (TS) phenotypes. Also, we examined the effects of age, gender, and female puberty (estrogen) on the LWD phenotype. SHOX deletions were present in affected individuals from 17 families (81%), and point mutations were detected in 4 families (19%). In the LWD subjects, height deficits ranged from -4.6 to +0.6 SD (mean +/- SD = -2.2 +/- 1.0). There were no statistically significant effects of age, gender, pubertal status, or parental origin of SHOX mutations on height z-score. The height deficit in LWD is approximately two thirds that of TS. Madelung deformity was present in 74% of LWD children and adults and was more frequent and severe in females than males. The prevalence of the Madelung deformity was higher in the LWD vs. a TS population. The prevalence of increased carrying angle, high arched palate, and scoliosis was similar in the two populations. In conclusion, SHOX deletions or mutations accounted for all of our LWD cases. SHOX haploinsufficiency accounts for most, but not all, of the TS height deficit. The LWD phenotype shows some gender- and age-related differences.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11739418     DOI: 10.1210/jcem.86.12.8125

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  35 in total

1.  A second recombination hotspot associated with SHOX deletions.

Authors:  Andrew R Zinn; Purita Ramos; Judith L Ross
Journal:  Am J Hum Genet       Date:  2006-03       Impact factor: 11.025

2.  Adult height in sixty girls with Turner syndrome treated with growth hormone matched with an untreated group.

Authors:  A M Pasquino; I Pucarelli; M Segni; L Tarani; V Calcaterra; D Larizza
Journal:  J Endocrinol Invest       Date:  2005-04       Impact factor: 4.256

3.  Near absent carrying angles: a clinical clue to underlying SHOX overdosage.

Authors:  Partha Pratim Chakraborty; Abhijit Mishra; Kalimujjaman Molla; Ratan Halder
Journal:  BMJ Case Rep       Date:  2019-03-31

Review 4.  Madelung's Deformity.

Authors:  Elisa J Knutsen; Charles A Goldfarb
Journal:  Hand (N Y)       Date:  2014-09

5.  The physical phenotype of girls and women with Turner syndrome is not X-imprinted.

Authors:  Carolyn A Bondy; Lea Ann Matura; Nicole Wooten; James Troendle; Andrew R Zinn; Vladimir K Bakalov
Journal:  Hum Genet       Date:  2007-01-23       Impact factor: 4.132

6.  Improving clinical diagnosis in SHOX deficiency: the importance of growth velocity.

Authors:  Giulia Genoni; Alice Monzani; Matteo Castagno; Roberta Ricotti; Anna Rapa; Antonella Petri; Deepak Babu; Mara Giordano; Flavia Prodam; Gianni Bona; Simonetta Bellone
Journal:  Pediatr Res       Date:  2017-12-06       Impact factor: 3.756

7.  The Human Pseudoautosomal Region (PAR): Origin, Function and Future.

Authors:  A Helena Mangs; Brian J Morris
Journal:  Curr Genomics       Date:  2007-04       Impact factor: 2.236

8.  Wrist anomalies in Turner syndrome compared with Leri-Weill dyschondrosteosis: a new feature in Turner syndrome.

Authors:  Maithé Tauber; Nadia Lounis; Julien Coulet; Christiane Baunin; Jean-Philippe Cahuzac; Pierre Rochiccioli
Journal:  Eur J Pediatr       Date:  2004-06-09       Impact factor: 3.183

9.  Effectiveness of the combined recombinant human growth hormone and gonadotropin-releasing hormone analog therapy in pubertal patients with short stature due to SHOX deficiency.

Authors:  Renata C Scalco; Suzana S J Melo; Patricia N Pugliese-Pires; Mariana F A Funari; Mirian Y Nishi; Ivo J P Arnhold; Berenice B Mendonca; Alexander A L Jorge
Journal:  J Clin Endocrinol Metab       Date:  2009-11-19       Impact factor: 5.958

10.  Enhancer deletions of the SHOX gene as a frequent cause of short stature: the essential role of a 250 kb downstream regulatory domain.

Authors:  J Chen; G Wildhardt; Z Zhong; R Röth; B Weiss; D Steinberger; J Decker; W F Blum; G Rappold
Journal:  J Med Genet       Date:  2009-07-02       Impact factor: 6.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.